Amanote Research

Amanote Research

    RegisterSign In

Is the Use of Esomeprazole in Gastroesophageal Reflux Disease a Cost-Effective Option in Poland?

Value in Health - United Kingdom
doi 10.1016/j.jval.2013.08.1119
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
Date

November 1, 2013

Authors
P. PetryszynA. Staniak
Publisher

Elsevier BV


Related search

Weight Loss Is Truly Effective in Reducing Symptoms and Proton Pump Inhibitor Use in Patients With Gastroesophageal Reflux Disease

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2015English

Gastroesophageal Reflux Disease

Turkish Thoracic Journal
PulmonaryRespiratory Medicine
2017English

Gastroesophageal Reflux Disease

2004English

Gastroesophageal Reflux Disease

Gastroenterology Nursing
MedicineGastroenterologySpecialized NursingAdvanced
2019English

Gastroesophageal Reflux Disease

English

The Role of pH in Symptomatic Relief and Effective Treatment of Gastroesophageal Reflux Disease

Przeglad Gastroenterologiczny
Gastroenterology
2017English

Alginates in the Treatment of Gastroesophageal Reflux Disease

Effective Pharmacotherapy
2020English

Dexansoprazole MV in the Treatment of Gastroesophageal Reflux Disease

Medical Council
2019English

Prevalence of Gastroesophageal Reflux Disease in Turkish Children Aged 3-6 Years Old; Development of Gastroesophageal Reflux Disease Questionnaire to Use for Turkish Children (Sm-2 Reflux Questionnaire)

Turkiye Klinikleri Pediatri
Child HealthPediatricsPerinatology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy